Prevention and Treatment of Cancer-Related Infections

Clicks: 136
ID: 114538
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Infectious diseases are important causes of morbidity and mortality in patients with cancer. In certain instances, the malignancy itself can predispose patients to severe or recurrent infections. Neutropenia has been recognized for many decades as a major risk factor, and effective strategies to anticipate, prevent, and manage infectious complications in patients with cancer experiencing neutropenia have led to improved outcomes. Reflecting the heterogeneity of immunocompromised conditions in patients with cancer and the spectrum of pathogens to which they are susceptible, NCCN expanded the scope of the Fever and Neutropenia Panel in 2007 to create guidelines on Prevention and Treatment of Cancer-Related Infections. These guidelines, newly updated for 2008, characterize major categories of immunologic deficits in persons with cancer and the major pathogens to which they are susceptible.For the most recent version of the guidelines, please visit NCCN.org
Reference Key
2008journalprevention Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal journal of the national comprehensive cancer network
Year 2008
DOI
10.6004/jnccn.2008.0013
URL
http://dx.doi.org/10.6004/jnccn.2008.0013
Keywords
immunity National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine community-acquired infections / epidemiology neoplasms / complications* practice guideline alison g freifeld communicable diseases / etiology communicable diseases / epidemiology* risk assessment antibiotic prophylaxis cellular community-acquired infections / prevention & control antifungal agents / therapeutic use mycoses / epidemiology soft tissue infections / prevention & control soft tissue infections / epidemiology immunocompromised host* virus diseases / prevention & control communicable diseases / immunology pneumococcal infections / prevention & control viral vaccines / administration & dosage pneumococcal infections / epidemiology adrenal cortex hormones / administration & dosage mycoses / prevention & control neoplasms / immunology pmid:18319048 doi:10.6004/jnccn.2008.0013 brahm h segal angelina s the cytomegalovirus infections / prevention & control neutropenia / epidemiology nose diseases / epidemiology nose diseases / prevention & control primary prevention* virus diseases / epidemiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.